TECX: Tectonic Therapeutic Inc. Company Short-Term Debt

Symbol and logo of brand tectonictx.com (TECX)

The share price of Tectonic Therapeutic, Inc. (TECX) visualized below on the GURU.Markets platform reaches 0.00. Tectonic Therapeutic, Inc. (TECX) focuses on protein modification to combat severe immune pathologies by targeting GPCR receptors. The business relies on closed research centers without direct sales, where development is driven by government regulatory bodies, and patented antibody developments serve as the primary asset.

TECX (tectonictx.com) Company Short-Term Debts history from 06/22/2024 to 11/01/2026

Analytical breakdowns and data insights for company Tectonic Therapeutic Inc. (TECX)

- current quotes and average value forecast:
Price Chart Tectonic|TECX - Fair Value Consensus
- market capitalization information:
Market Value Tectonic Therapeutic, Inc.|TECX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Tectonic Therapeutic|TECX - Book Capitalization|Market Cap to Net Assets Ratio tectonictx.com|TECX - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Tectonic Therapeutic, Inc.|TECX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Tectonic|TECX - Company Cumulative Indebtedness|Debts to Book Capitalization Tectonic Therapeutic, Inc.|TECX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Tectonic Therapeutic|Quick Liquidity tectonictx.com
- net income and valuation multiples indicators:
TECX - Final Profit
Summary company analytics:tectonictx.com (TECX)
Mass-produced product of Tectonic Therapeutic, Inc.

Complex protein development and lengthy FDA trials require colossal capital expenditures from Tectonic Therapeutic, Inc. (TECX). Analyzing the short-term debt portfolio, an investor sees the total amount of all liabilities maturing within one year. The current value of 0.00 reflects the operational load and liquidity of the business. A decline in this curve confirms the company's financial autonomy. However, excessive reduction of borrowings may limit the pace of bioengineering development.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Verona Pharma Corp (VRNA) - Company Short-Term Debt|Company Current Liabilities Jyong Bio|LGND (Ligand Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts amneal.com|Company Current Liabilities PRGO (Perrigo)|ALVO (Alvotech S.A.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Liquidia Technologies LQDA|Galapagos Corp (GLPG) - Short-Term Debt|ANIP: Company Current Liabilities|mannkindcorp.com - Amount of Current Liabilities|AMPH: Company Short-Term Debts|Pacira Pharmaceuticals - Company Short-Term Loans and Borrowings|SPRY (ARS Pharma) - Company Short-Term Debts|Short-Term Debt Theravance Corp TBPH|Company Short-Term Debt Aquestive Therapeutics (AQST)|SCPH (scpharmaceuticals.com) - Company Short-Term Loans and Borrowings|Tonix Pharmaceuticals Holding Corp. - Company Current Liabilities|Amount of Current Liabilities SXTC (SXT Pharmaceuticals)|Eupraxia Pharma - Company Short-Term Debts|Short-Term Debt BioHarvest Sciences Inc|EXOZ: Company Short-Term Debts|Company Current Liabilities Oramed Pharmaceuticals Inc.|Company Current Liabilities ENTX|HYFT (MindWalk Holdings, Inc.) - Amount of Current Liabilities|Company Short-Term Debt ABVC BioPharma Inc (ABVC)|CPIX - Short-Term Debt|Company Short-Term Debt Quantum BioPharma Ltd QNTM|FGEN: Company Short-Term Indebtedness|Telomir Pharmaceuticals, Inc. - Company Short-Term Debts|Short-Term Debt Volume Rani Therapeutics RANI|SNYR: Company Short-Term Debts|Company Current Liabilities Rallybio|Company Current Liabilities LEXX|PULM: Company Short-Term Loans and Borrowings|Company Current Liabilities PTHL (Pheton Holdings Ltd)|Amount of Current Liabilities APM|Company Short-Term Debts LYRA (Lyra Therapeutics, Inc)|Company Short-Term Loans and Borrowings IBO|TNF Pharma - Company Short-Term Debts|Short-Term Debt cbdMD, Inc.|PainReform (PRFX) - Company Short-Term Debt|Altamira Therapeutics Ltd. - Company Short-Term Loans and Borrowings|LIPO (Lipella) - Company Short-Term Debts|Company Short-Term Debts OptiNose Corp|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC: Current Liabilities|Company Short-Term Debts PTPI (Petros Pharmaceuticals, Inc.)|Qilian International Holding Group (QLI) - Short-Term Debt|SLRN: Company Current Liabilities|TFFP - Company Short-Term Debts